Global Auto-Injectors Market Will Reach 2950 Million US$ by the End of 2025
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
Los Angeles, CA -- (SBWire) -- 01/11/2019 --This report studies the global Auto-Injectors market status and forecast, categorizes the global Auto-Injectors market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Auto-injector is a medical device designed to deliver a dose of a particular drug.
Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks.
Auto-Injectors are expected to present vast opportunities to investors due to high demand in biologics development. Overall revenues from the pre-filled syringes segment is expected to grow during the forecast period due to the rising need for targeted and sustained drug delivery.
The global average price of Auto-Injectors is in the increasing trend from 2013-2016, Auto-injectors manufacturers are introducing generic versions in order to reduce the overall cost of the device. In order to better serve anaphylaxis patients with epinephrine at an affordable cost, Mylan N.V. has implemented the decision of introducing the generic version of Epipen at half the price.
The classification of Auto-Injectors includes reusable Auto-Injectors and disposable Auto-Injectors, and the proportion of disposable Auto-Injectors in 2017 is about 62.7%, and the proportion is in increasing trend from 2013 to 2017.
Auto-injectors are pen like devices used to deliver a fixed dose of drug to patients and are intended for self-administration. Auto-injectors are gradually becoming the gold-standard in the treatment of various indications like anaphylaxis, multiple sclerosis, rheumatoid arthritis and others. The most proportion of Auto-Injectors is used for Anaphylaxis, and the proportion in 2017 is 56.9%.
North America is the largest consumption place, with a consumption market share nearly 59.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 20%. China is also an important sales region.
Request Sample Report Copy@ https://www.qyresearch.com/sample-form/form/139776/global-auto-injectors-market
Market competition is not intense. Mylan, BD, Johnson & Johnson, Amgen Inc., etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Auto-Injectors market is valued at 1660 million US$ in 2017 and will reach 2950 million US$ by the end of 2025, growing at a CAGR of 7.5% during 2018-2025.
The major manufacturers covered in this report
Johnson & Johnson
Antares Pharma, Inc.
Medeca Pharma AB
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
Get Amazing Discount on Market Research Report@ https://www.qyresearch.com/request-discount/form/139776/global-auto-injectors-market
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Media Relations Contact
Director - Digital Marketing
View this press release online at: http://rwire.com/1121039